...
机译:乳腺癌SELDI-TOF MS血清蛋白谱:稳健性和有效性评估
Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands;
Department of Clinical Chemistry, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands;
Department of Surgery, Slotervaart Hospital, Amsterdam, The Netherlands;
Department of Surgery, Slotervaart Hospital, Amsterdam, The Netherlands;
Department of Surgery, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands;
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands;
Biomarkers; robustness; validity; SELDI-TOF MS; breast cancer;
机译:通过SELDI-TOF MS进行蛋白质谱分析,在分级血清样品中搜索乳腺癌生物标志物
机译:使用SELDI-TOF MS进行血清蛋白谱分析以诊断乳腺癌。
机译:样品处理方法的变化对结直肠癌SELDI-TOF MS血清蛋白谱的影响
机译:MCF7乳腺癌细胞蛋白质差异表达分析的ITRAQ-RPLC-MS / MS方法:迈向生物标志物发现
机译:基于LC-MS / MS的乳腺癌细胞代谢谱分析。
机译:比较旧的和新一代的SELDI-TOF MS:对血清蛋白谱分析的影响
机译:通过Seldi-Tof MS的蛋白质分析在分级血清样品中搜索乳腺癌生物标志物